Plasma glycolipids levels: new factors regulating the protein C anticoagulant pathway and determining thrombotic risk

Group V secretory phospholipase A2 impairs endothelial protein C receptor-dependent protein C activation and accelerates thrombosis in vivo.

Journal of thrombosis and haemostasis : JTH·2014

Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.

Journal of thrombosis and haemostasis : JTH·2014

Factor VIIa binding to endothelial cell protein C receptor protects vascular barrier integrity in vivo.

Journal of thrombosis and haemostasis : JTH·2014

Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis).

Journal of thrombosis and haemostasis : JTH·2012

Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

Journal of thrombosis and haemostasis : JTH·2012

Innate immunity and coagulation.

Journal of thrombosis and haemostasis : JTH·2011

TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.

Blood·2026

Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients.

Blood·2026

STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.

Blood·2026

Diagnosis and Management of Chronic Lymphocytic Leukemia with TP53 Loss of Function in the Novel Agent Era.

Blood·2026

Piezo 1 and Shear-induced Erythrocyte Transformation and Procoagulant Activity: Implication for LVAD-Induced Bleeding.

Blood·2026

Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.

Blood·2026

Impact of Ganglionated Plexus Ablation on Early Recurrence After Thoracoscopic Atrial Fibrillation Ablation: A Post Hoc Analysis of the AFACT Study.

Journal of cardiovascular electrophysiology·2026

Tissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma.

Future oncology (London, England)·2026

Hidden in Plain Sight: The Diagnostic Odyssey of Glomus Tumors.

Cureus·2026

HepaKineticNet: Deep Learning of CT-Derived Intratumoral Heterogeneity for Overall Survival Prediction in BCLC Stage B-C Hepatocellular Carcinoma Treated with Locoregional Therapy Plus First-Line TKI and Anti-PD-1 Therapy.

Journal of hepatocellular carcinoma·2026

Systematic Literature Review of the Efficacy and Safety of Treatments in Congenital Thrombotic Thrombocytopenic Purpura.

Journal of blood medicine·2026

CD5-Positive Mature B-Cell Neoplasm With Large-Cell Morphology, Predominant Bone Marrow Involvement, and a Leukemic Peripheral Blood Presentation: A Case Report.

Case reports in hematology·2026

Related Experiment Videos

Plasma glycolipids levels: new factors regulating the protein C anticoagulant pathway and determining thrombotic risk

Related Concept Videos

Group V secretory phospholipase A2 impairs endothelial protein C receptor-dependent protein C activation and accelerates thrombosis in vivo.

Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells.

Factor VIIa binding to endothelial cell protein C receptor protects vascular barrier integrity in vivo.

Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis).

Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

Innate immunity and coagulation.

TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.

Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients.

STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell lymphoma.

Diagnosis and Management of Chronic Lymphocytic Leukemia with TP53 Loss of Function in the Novel Agent Era.

Piezo 1 and Shear-induced Erythrocyte Transformation and Procoagulant Activity: Implication for LVAD-Induced Bleeding.

Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.

Impact of Ganglionated Plexus Ablation on Early Recurrence After Thoracoscopic Atrial Fibrillation Ablation: A Post Hoc Analysis of the AFACT Study.

Tissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma.

Hidden in Plain Sight: The Diagnostic Odyssey of Glomus Tumors.

HepaKineticNet: Deep Learning of CT-Derived Intratumoral Heterogeneity for Overall Survival Prediction in BCLC Stage B-C Hepatocellular Carcinoma Treated with Locoregional Therapy Plus First-Line TKI and Anti-PD-1 Therapy.

Systematic Literature Review of the Efficacy and Safety of Treatments in Congenital Thrombotic Thrombocytopenic Purpura.

CD5-Positive Mature B-Cell Neoplasm With Large-Cell Morphology, Predominant Bone Marrow Involvement, and a Leukemic Peripheral Blood Presentation: A Case Report.

Related Experiment Videos

Plasma glycolipids levels: new factors regulating the protein C anticoagulant pathway and determining thrombotic risk

Related Concept Videos

Related Articles